首页> 外文期刊>Cytotherapy >Identification of senescent cells in multipotent mesenchymal stromal cell cultures: Current methods and future directions
【24h】

Identification of senescent cells in multipotent mesenchymal stromal cell cultures: Current methods and future directions

机译:多能间充质细胞培养物中衰老细胞的鉴定:目前的方法和未来方向

获取原文
获取原文并翻译 | 示例
           

摘要

Regardless of their tissue of origin, multipotent mesenchymal stromal cells (MSCs) are commonly expanded in vitro for several population doublings to achieve a sufficient number of cells for therapy. Prolonged MSC expansion has been shown to result in phenotypical, morphological and gene expression changes in MSCs, which ultimately lead to the state of senescence. The presence of senescent cells in therapeutic MSC batches is undesirable because it reduces their viability, differentiation potential and trophic capabilities. Additionally, senescent cells acquire senescence-activated secretory phenotype, which may not only induce apoptosis in the neighboring host cells following MSC transplantation, but also trigger local inflammatory reactions. This review outlines the current and promising new methodologies for the identification of senescent cells in MSC cultures, with a particular emphasis on non-destructive and label-free methodologies. Technologies allowing identification of individual senescent cells, based on new surface markers, offer potential advantage for targeted senescent cell removal using new-generation senolytic agents, and subsequent production of therapeutic MSC batches fully devoid of senescent cells. Methods or a combination of methods that are non-destructive and label-free, for example, involving cell size and spectroscopic measurements, could be the best way forward because they do not modify the cells of interest, thus maximizing the final output of therapeutic-grade MSC cultures. The further incorporation of machine learning methods has also recently shown promise in facilitating, automating and enhancing the analysis of these measured data.
机译:无论它们的原产地,多能间充质基质细胞(MSCs)通常在体外扩增几种群体倍增,以达到足够数量的疗法。已经显示出延长的MSC膨胀导致MSC的表型,形态学和基因表达变化,最终导致衰老状态。治疗性MSC批次中衰老细胞的存在是不希望的,因为它降低了它们的活力,分化潜力和营养能力。另外,衰老细胞获得衰老活化的分泌表型,这不仅可能在MSC移植后诱导相邻宿主细胞中的细胞凋亡,而且引发局部炎症反应。本综述概述了MSC培养物中衰老衰老细胞的当前和有希望的新方法,特别强调无损和无标签的方法。允许鉴定基于新的表面标记的个体衰老细胞的技术,提供了使用新一代森林药剂的患者衰老细胞去除潜在的优势,并随后产生治疗性MSC批次的生产完全没有衰老细胞。方法或无损性和无标记的方法的组合,例如,涉及细胞尺寸和光谱测量,可能是前进的最佳方式,因为它们不改变感兴趣的细胞,从而最大化治疗的最终输出 - 等级MSC培养物。最近还将机器学习方法的进一步纳入了促进,自动化和增强这些测量数据的分析的承诺。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号